drugmaker, broadening its reach in emerging markets and adding a remedy for smokers��� cough to its portfolio. Takeda, Asia���s largest drugmaker, will pay cash for Zurich- based Nycomed, which is controlled by Nordic Capital and Credit Suisse Group...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Takeda to Buy Nycomed for 9.6 Bln Euros to Fill Sales Gap
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account